Federal Circuit Upholds Ruling Favoring Impax In Suit Over Wellbutrin, Zyban ANDAs
The Court of Appeals for the Federal Circuit has upheld a lower court's decision against GlaxoSmithKline over generics maker Impax Laboratories' abbreviated new drug applications for certain dosages of Wellbutrin and...To view the full article, register now.
Already a subscriber? Click here to view full article